Ivory, an early-stage brain health startup, has announced the successful close of its latest $1 million funding round. The round was co-led by IIM-A Ventures, the entrepreneurship centre at IIM Ahmedabad, and Capital-A, which had previously backed Ivory in the pre-seed stage.
The funding round saw additional backing from 1Crowd and Stanford Angels, along with eminent angel investors such as Dr Sanjay Arora, Adarsh Narahari and Juhi Bhatnagar.
With no definitive cure for neurodegenerative conditions like dementia, prevention is the only real defence. Ivory aims to shift the focus from late-stage diagnosis to proactive brain health solutions. Through neuroscience-based digital assessments, it aims to enable early detection of cognitive decline, empowering individuals to take action long before symptoms escalate.
With this new capital, Ivory plans to strengthen the technology for its clinical-grade assessments and scale distribution to reach more individuals across India.
In the past year, apart from being directly available to consumers through its app, Ivory has also built a pipeline of clinicians, psychologists, insurance and corporate partners, like Ather Energy, WeWork and PUMA, who are relying on Ivory to power their cognitive risk screenings.
The startup recently released a Brain Health Report, offering insights into the state of cognitive well-being in the country. Ivory also gained national visibility through its appearance on Shark Tank India Season 4.
Looking ahead, the team plans to expand its footprint across new geographies, deepen AI capabilities to personalise assessments further, and invest in longitudinal research.